AxioMed Spine

AxioMed Spine

AxioMed Spine develops products that restore the spinal function of patients with degenerative spine diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€44—65m (Dealroom.co estimates Aug 2022.)
Malden Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

$2.8m

Series A

$18.0m

Series B
N/A

$6.4m

Series C
N/A

$9.5m

Early VC
N/A

$15.0m

Series D
N/A

$500k

Grant
N/A

$5.0m

Series D

$3.6m

Series D
N/A

$1.1m

Debt
N/A

$1.0m

Debt
*
N/A

$12.0m

Late VC
Total Funding€66.2m

Recent News about AxioMed Spine

Edit
More about AxioMed Spineinfo icon
Edit

Axiomed is a pioneering company in the medical device industry, specializing in next-generation total disc replacement solutions. The company focuses on developing innovative, one-piece disc replacement devices designed to provide both flexibility and support, thereby facilitating pain relief and the restoration of normal spinal function for patients suffering from degenerative disc disease. Axiomed serves a diverse range of clients, including healthcare providers, hospitals, and clinics that treat spinal conditions. Operating in the global medical device market, Axiomed's business model revolves around the research, development, and commercialization of advanced spinal care technologies. The company generates revenue through the sale of its proprietary disc replacement devices and related services. By leveraging cutting-edge technology and a patient-centric approach, Axiomed aims to redefine patient outcomes and improve the quality of life for individuals with spinal disorders.

Keywords: total disc replacement, spinal care, degenerative disc disease, pain relief, spinal function, medical device, healthcare, innovation, patient outcomes, technology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.